Ketamine for Depression, 3: Does Chirality Matter?
The Journal of Clinical Psychiatry · 28.06.2017 · 78 (06) · e674-e677
DOI: 10.4088/jcp.17f11681 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift The Journal of Clinical Psychiatry, erschienen am 28.06.2017. Verfasst von Chittaranjan Andrade. Beteiligte Einrichtung: Department of Psychopharmacology, National Institute of Mental Health and Neurosciences, Bangalore, India. candrade@psychiatrist.com. Hauptthemen laut MEDLINE: Stereoisomerism. Die Arbeit wurde bisher 72-mal zitiert (Crossref).
Themen: Depression
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Psychopharmacology, National Institute of Mental Health and Neurosciences, Bangalore, India. candrade@psychiatrist.com.
Zitieren
APA
Andrade, C. (2017). Ketamine for Depression, 3: Does Chirality Matter?. The Journal of Clinical Psychiatry, 78(06), e674-e677. https://doi.org/10.4088/jcp.17f11681
Vancouver
Andrade C. Ketamine for Depression, 3: Does Chirality Matter?. The Journal of Clinical Psychiatry. 2017;78(06):e674-e677. doi:10.4088/jcp.17f11681
BibTeX
@article{Andrade2017,
author = {Andrade, Chittaranjan},
title = {Ketamine for Depression, 3: Does Chirality Matter?},
journal = {The Journal of Clinical Psychiatry},
year = {2017},
volume = {78},
number = {06},
pages = {e674--e677},
doi = {10.4088/jcp.17f11681}
}
EUVIMED